Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.

Thomas MuleyFelix J HerthClaus Peter HeusselMark KriegsmannThomas MichaelMichael MeisterMarc A SchneiderBirgit WehnlAnika MangStefan Holdenrieder

Published in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2023)

The results indicate the great potential of ProGRP, NSE and CYFRA 21-1 for estimating prognosis and monitoring of SCLC patients throughout the course of the disease.

Keyphrases

small cell lung cancer
end stage renal disease
chemotherapy induced
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
risk assessment
human health